These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 33193122)

  • 1.
    Zhou C; Wang Q; Jin L; Wang R; Yin Y; Sun S; Zhang J; Wang H
    Front Microbiol; 2020; 11():533209. PubMed ID: 33193122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo Effect of Antimicrobial Agent Combinations Against Carbapenem-Resistant
    Liu E; Jia P; Li X; Zhou M; Kudinha T; Wu C; Xu Y; Yang Q
    Infect Drug Resist; 2021; 14():917-928. PubMed ID: 33707959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meropenem-Vaborbactam Activity against Carbapenem-Resistant
    Castanheira M; Doyle TB; Kantro V; Mendes RE; Shortridge D
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay.
    Pournaras S; Vrioni G; Neou E; Dendrinos J; Dimitroulia E; Poulou A; Tsakris A
    Int J Antimicrob Agents; 2011 Mar; 37(3):244-7. PubMed ID: 21236643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of double- and triple-antibiotic combinations for VIM- and NDM-producing Klebsiella pneumoniae by in vitro time-kill experiments.
    Tängdén T; Hickman RA; Forsberg P; Lagerbäck P; Giske CG; Cars O
    Antimicrob Agents Chemother; 2014; 58(3):1757-62. PubMed ID: 24395223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro evaluation of different antimicrobial combinations against carbapenemase-producing Klebsiella pneumoniae: the activity of the double-carbapenem regimen is related to meropenem MIC value.
    Oliva A; Scorzolini L; Cipolla A; Mascellino MT; Cancelli F; Castaldi D; D'Abramo A; D'Agostino C; Russo G; Ciardi MR; Mastroianni CM; Vullo V
    J Antimicrob Chemother; 2017 Jul; 72(7):1981-1984. PubMed ID: 28369424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic activity of fosfomycin-meropenem and fosfomycin-colistin against carbapenem resistant
    Bakthavatchalam YD; Shankar A; Muthuirulandi Sethuvel DP; Asokan K; Kanthan K; Veeraraghavan B
    Future Sci OA; 2020 Feb; 6(4):FSO461. PubMed ID: 32257374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbapenem-Resistant
    Ramadan RA; Bedawy AM; Negm EM; Hassan TH; Ibrahim DA; ElSheikh SM; Amer RM
    Infect Drug Resist; 2022; 15():3537-3548. PubMed ID: 35833009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro effect of an antimicrobial combination therapy without colistin and tigecycline for CPE and non-CPE.
    Okanda T; Matsumoto T
    J Infect Chemother; 2020 Apr; 26(4):322-330. PubMed ID: 31924522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Types of Carbapenemase and Clinical Outcomes of Infection Due to Carbapenem Resistance Enterobacterales.
    Pudpong K; Pattharachayakul S; Santimaleeworagun W; Nwabor OF; Laohaprertthisan V; Hortiwakul T; Charernmak B; Chusri S
    Infect Drug Resist; 2022; 15():3025-3037. PubMed ID: 35720254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro Synergistic Activities of Fosfomycin in Combination with Other Antimicrobial Agents Against Carbapenem-Resistant
    Kaewnirat K; Chuaychob S; Chukamnerd A; Pomwised R; Surachat K; Phoo MTP; Phaothong C; Sakunrang C; Jeenkeawpiam K; Hortiwakul T; Charernmak B; Chusri S
    Infect Drug Resist; 2022; 15():1777-1791. PubMed ID: 35437346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of tigecycline alone or in combination for experimental infections by KPC carbapenemase-producing Klebsiella pneumoniae.
    Fergadaki S; Renieris G; Machairas N; Sabracos L; Droggiti DI; Misiakos E; Giamarellos-Bourboulis EJ
    Int J Antimicrob Agents; 2021 Sep; 58(3):106384. PubMed ID: 34161789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fosfomycin-meropenem synergistic combination against NDM carbapenemase-producing Klebsiella pneumoniae strains.
    Della Rocca MT; Di Caprio G; Colucci F; Merola F; Panetta V; Cordua E; Greco R
    New Microbiol; 2023 Sep; 46(3):264-270. PubMed ID: 37747471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of pandrug-resistant carbapenemase-producing
    Tartor YH; Ammar AM; Abdelkhalek A; Hassan KA; Shaker A; Elnahriry SS; Nekouei O; Elsohaby I
    Front Cell Infect Microbiol; 2024; 14():1318585. PubMed ID: 38562962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of colistin alone and in various combinations for the treatment of experimental osteomyelitis due to carbapenemase-producing Klebsiella pneumoniae.
    Crémieux AC; Dinh A; Nordmann P; Mouton W; Tattevin P; Ghout I; Jayol A; Aimer O; Gatin L; Verdier MC; Saleh-Mghir A; Laurent F
    J Antimicrob Chemother; 2019 Sep; 74(9):2666-2675. PubMed ID: 31263884
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Cebrero-Cangueiro T; Álvarez-Marín R; Labrador-Herrera G; Smani Y; Cordero-Matía E; Pachón J; Pachón-Ibáñez ME
    Front Cell Infect Microbiol; 2018; 8():363. PubMed ID: 30406040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triple combination of meropenem, colistin and tigecycline was bactericidal in a dynamic model despite mere additive interactions in chequerboard assays against carbapenemase-producing Klebsiella pneumoniae isolates.
    Tsala M; Vourli S; Georgiou PC; Pournaras S; Daikos GRL; Mouton JW; Meletiadis J
    J Antimicrob Chemother; 2019 Feb; 74(2):387-394. PubMed ID: 30376071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of In Vitro Activity of Double-Carbapenem Combinations against KPC-2-, OXA-48- and NDM-Producing
    Allander L; Vickberg K; Lagerbäck P; Sandegren L; Tängdén T
    Antibiotics (Basel); 2022 Nov; 11(11):. PubMed ID: 36421290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity and post-antibiotic effects of colistin in combination with other antimicrobials against colistin-resistant KPC-producing Klebsiella pneumoniae bloodstream isolates.
    Gaibani P; Lombardo D; Lewis RE; Mercuri M; Bonora S; Landini MP; Ambretti S
    J Antimicrob Chemother; 2014 Jul; 69(7):1856-65. PubMed ID: 24648503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colistin Combined With Tigecycline: A Promising Alternative Strategy to Combat
    Zhou YF; Liu P; Zhang CJ; Liao XP; Sun J; Liu YH
    Front Microbiol; 2019; 10():2957. PubMed ID: 31969868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.